Familial hypercholesterolaemia

structured review at least annually to people with FH. People with FH are offered a detailed review of their condition at least once a year. Source guidance Familial hypercholesterolaemia: identification and management. NICE guideline CG71 (2008, updated 2019), recommendations 1.3.1.27, 1.4.2.1, 1.4.3.2, and 1.5.1.1 to 1.5.1.5 Definitions of terms used in this quality statement Familial hypercholesterolaemia (FH) FH relates to heterozygous FH only. People with FH People should have a diagnosis of FH made by a specialist with expertise in FH. Structured review Structured review should include all the following components if appropriate: • recording progress of cascade testing among relatives • updating the family pedigree and noting changes in the coronary heart disease status of relatives • assessing any symptoms of coronary heart disease • assessing smoking status, and offering advice and information on smoking cessation services • measuring fasting lipid profile • discussing adherence to treatment, and possible side effects of treatment the person may be experiencing • discussing any changes in lifestyle or lipid-modifying drug treatment that may be needed to achieve the recommended LDL-C concentration • giving advice on contraception and pregnancy (to women and girls only) • monitoring growth and pubertal development (in children and
